REGISTER now: Visser ai webinar - BEYOND THE HYPE: AI IN PATENT PROSECUTION
​

The UPC
Hub

Case reports, trends, insights and the litigators behind them, in one place.

Link copied
Download The UPC ReviewUPC Decisions

Ready for the UPC long before it opened.

We have run patent litigation across the UK and Germany for well over a decade. When the UPC opened in June 2023, our Uniphy team was ready from day one.

Our litigators and patent attorneys work as one team across UPC, UK and German proceedings.

Tap a year to explore

Established UK and German litigation practices

  • Built experience across electronics, telecoms, pharma and medtech
  • Integrated patent attorneys and litigators

Ran major cross-border actions across the UK and Germany

  • Handled FRAND, SEP and multi-jurisdictional disputes
  • Prepared for pan-European litigation long before the UPC existed

UPC goes live and we launch Uniphy

  • 40 UPC Representatives at launch
  • Seamless transition into UPC litigation from day one
Thought leadership

Our latest thinking on the UPC

See all thought leadership
Chinese companies13 Aug 2026
38%

of 2025 infringement actions at the UPC involved a Chinese party.

Chinese companies and the UPC: from enforcement targets to strategic users

The UPC's 2025 Annual Report shows Chinese parties playing a growing part in UPC litigation. We look at what that means.

Read the article →
SEP and FRAND7 Jun 2026

Choosing your SEP battleground: UPC, Germany or UK?

The key points SEP owners should weigh when choosing where to litigate.

Read the article →
Procedure21 Jan 2026

Confidentiality at the UPC: what litigants need to know

How sensitive information is protected, and when hearings can be private.

Read the article →
Biopharma13 Apr 2026

Biopharma strategy in 2026: lessons from 2025 on AI, M&A and the UPC

What biopharma teams can take from 2025 as they plan for 2026.

Read the article →
UK and the UPC26 Jun 2025

Unified Patent Court: the impact of Brexit

Could the UK take part in the UPC without rejoining the EU?

Read the article →
Outcomes

How UPC cases turn out

View more UPC statistics

The results of decided cases, with the median time the Court took. Hover or tab through the lists to explore.

Case reports

Read what the Court is deciding

Tags
No tags match that search.
Court
No courts match that search.
Sector
No sectors match that search.
0 of 100
Case Reports
Tag
Clear all
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Clear all
​
Tag
:
Tag

Samsung v Apple tablet battle hits the UK

05 April 2012
2012-04-05

The ongoing dispute between Apple and Samsung over Apple's Registered Community Designs for its iPad has now entered the UK courts.Darren Smyth's latest IPKat post relates to a decision of Mr Justice...

#
Digital
#
Building a Resilient Quantum Patent Portfolio: Winning the Race to File First
No items found.
No items found.
​

Poland's law on cheap drugs declared contrary to EU law

03 April 2012
2012-04-03

A Polish law which allowed the sale of unapproved drugs which were cheaper than those approved has been declared contrary to EU law.The decision by the Court of Justice of the European Union is...

#
Life
No items found.
No items found.
​

Regeneron Pharmaceuticals Inc, Bayer Pharma AG v Genentech Inc

29 March 2012
2012-03-29

In today's IPKat, Darren Smyth analyses the decision in Regeneron Pharmaceuticals Inc, Bayer Pharma AG v Genentech Inc, a case which started as an action for a declaration of invalidity of...

#
Life
No items found.
No items found.
​

AstraZeneca patent revoked for obviousness

29 March 2012
2012-03-29

In a decision on 22 March in Teva and ors v AstraZeneca concerning a patent on a sustained release formulation of an anti-psychotic drug, Mr Justice Arnold revoked the patent due to obviousness.

#
Life
No items found.
No items found.
​

UK Government confirms Patent Box scheme

27 March 2012
2012-03-27

Chancellor George Osborne confirmed in his 2012 Budget that the proposed Patent Box scheme will go ahead.When fully phased in, the rate of Corporation Tax on profits attributed to patents will be 10%.

#
Life
#
Patent Strategy
No items found.
No items found.
​

EPO publishes draft version of revised Guidelines for Examination 2012

26 March 2012
2012-03-26

The European Patent Office (EPO) has published the draft version of revised Guidelines for Examination 2012 online.Partner Darren Smyth casts his eye over the draft version in his latest IPKat post.

#
Elements
No items found.
No items found.
​

Compulsory licensing in India – Must products be manufactured locally?

16 March 2012
2012-03-16

The first compulsory licence of an Indian patent since the TRIPS regime was implemented in India has been awarded. Although the licence relates to a pharmaceutical product, the grounds on which the...

#
Life
#
Patent Strategy
No items found.
No items found.
​

TRIPS and compulsory licensing

15 March 2012
2012-03-15

Following on from his IPKat post about India granting its first compulsory licence, Darren Smyth explores what limitations the TRIPS agreement puts on compulsory licensing in his latest blog.

#
Life
No items found.
No items found.
​

India grants first compulsory licence

14 March 2012
2012-03-14

The first compulsory licence has been granted by the Controller of Patents Mumbai.The application concerns the anti-cancer drug Sorafenib, a patented drug owned by Bayer Corporation.

#
Life
No items found.
No items found.
​

Scientific publishing: learned society journals v commercial alternatives

09 March 2012
2012-03-09

The subject of today's IPKat post - The Cost of Knowledge - by Darren Smyth concerns a campaign against Elsevier, the publisher of academic journals.

#
Elements
No items found.
No items found.
​

EPO Boards of Appeal: recent decisions

05 March 2012
2012-03-05

Recent decisions of the Boards of Appeal of the EPO are now updated continuously on the EPO website.In today's IPKat blog, Darren Smyth highlights some noteworthy cases from the first two months of...

#
Elements
No items found.
No items found.
​

Owning Community registered design provides no protection from infringement proceedings

02 March 2012
2012-03-02

SummaryThe Court of Justice of the European Union (CJEU) has confirmed that owning a Community registered design (CRD) does not provide a defence to an infringement action relating to earlier CRDs.

#
Building a Resilient Quantum Patent Portfolio: Winning the Race to File First
No items found.
No items found.
​

EPO and Google launch patent translation service

29 February 2012
2012-02-29

The European Patent Office (EPO) has launched a new patent translation service which uses Google's Translate technology.Reported by partner Darren Smyth via his IPKat blog, the service initially...

#
Elements
No items found.
No items found.
​

Novartis Pharmaceuticals UK Ltd v Medimmune Ltd & Anor – Self-perpetuating references to the CJEU

24 February 2012
2012-02-24

Multiple rulings of the CJEU on the SPC Regulation fail to answer questions posed by the national courts, result in greater confusion and give rise to a need for yet more references.

#
Litigation
#
Life
No items found.
No items found.
​

Colour and Composition: Just how relevant are they?

23 February 2012
2012-02-23

The issues of colour and composition form the basis of the questions referred to the CJEU by the Court of Appeal in this case of Specsavers International Healthcare & ors v Asda Stores Ltd.

#
Trademarking
No items found.
No items found.
​
No results found.
Please try updating your search criteria.
Speak to an expert

Meet our UPC team

Our team includes leading Attorneys-at-Law in Germany, technically skilled European patent attorneys, and highly reputed UK solicitors with experience in some of the largest European patent cases. With specialists based in Germany, Sweden (home to the UPC’s only regional division), and the UK (Europe’s largest litigation venue outside the UPC), we field formidable teams tailored to each case.

Our attorneys have worked together successfully for many years, enabling us to respond quickly and intelligently under the UPC’s tight timelines and new procedures. We offer clients a single point of contact for co-ordinated, cross-border litigation support.

‍

Christof Höhne
Partner, Rechtsanwalt, UPC Representative
Jerome Spaargaren
Partner, UK and European Patent Attorney, UPC Representative
Matthew Blaseby
Partner, UK and European Patent Attorney, UPC Representative
Michael Nielsen
Partner, UK and European Patent Attorney, UPC Representative
Darren Smyth
Partner, UK and European Patent Attorney, Design Attorney, UPC Representative
Monika Rai
Partner, UK and European Patent Attorney, Solicitor, UPC Representative
Isabelle Schaller
Partner, Rechtsanwältin, UPC Representative
Sebastian Fuchs
Partner, Rechtsanwalt, UPC Representative
Gareth Probert
Partner, UK and European Patent Attorney, UPC Representative
Heather McCann
Partner, UK and European Patent Attorney, UPC Representative
James Seymour
Partner, UK and European Patent Attorney, UPC Representative
Catherine Howell
Partner, Solicitor

Contact us

We’d love to hear from you. Whether you're exploring ways to protect, manage or maximise the value of your intellectual property, we are here to provide tailored support and strategic insight.

Please complete the form below and we will be in touch shortly.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form. Please try again.
​
Interested in a career at EIP?

View Open Roles